相关实验视频

Updated: May 16, 2025

Analytical Determination of Mitochondrial Function of Excised Solid Tumor Homogenates

Analytical Determination of Mitochondrial Function of Excised Solid Tumor Homogenates

Published on: August 6, 2021

向瘤治疗中的脆弱性:二基酸脱酶

Fu Lin¹, Jiaxin Li², Lei Zhou³

¹Department of Pathology, School of Basic Medicine and Forensic Science, Baotou Medical College, Baotou 014040, China.

|April 5, 2025

概括

氨酸脱酶 (DHODH) 是癌症代谢和细胞命运中的关键酶. DHODH 抑制剂在临床前瘤模型中显示出前途,但在临床试验中面临挑战,需要进一步研究有效的癌症疗法.

科学领域:

生物化学生物化学
在瘤学瘤学.
分子生物学分子生物学

背景情况:

氨酸脱酶 (DHODH) 是新型胺酸生物合成途径中的关键酶.
DHODH在调节瘤代谢,细胞命运和瘤信号传递方面发挥着重要作用.
它越来越被认为是各种癌症类型的关键治疗标.

研究的目的:

审查DHODH在癌症中的多方面的作用,包括其结构特征,代谢调节和参与瘤信号传递.
在临床前和临床癌症研究中分析DHODH抑制剂的疗效和挑战.
提出未来的研究方向,以克服DHODH向瘤疗法的临床应用中的障碍.

主要方法:

文献综述侧重于DHODH在瘤代谢,信号和耐药性的作用.
在各种癌症模型中分析DHODH抑制剂的临床前数据.
评估与DHODH抑制剂相关的临床试验结果和挑战.

主要成果:

DHODH的独特结构促进了各种生物功能,控制了瘤代谢和细胞命运.
DHODH充当代谢信号中心,激活瘤信号,促进转移,并调解药物耐药性.
DHODH 抑制剂在临床前瘤模型中显示出显著的疗效.

结论:

由于其在瘤代谢和信号传递中的中心作用,DHODH是瘤学的重要目标.
由于与药物相关的限制和外部约束,DHODH抑制剂的临床转化受到阻碍.
未来的研究必须解决这些挑战,以建立针对DHODH向癌症治疗的系统框架.

关键词:

DHODH DHODH 在线阅读这是一种DHODH抑制剂.铁化是铁化的一种.线粒体中的线粒体.皮里米丁是什么皮里米丁是什么瘤是一个瘤.

更多相关视频

Pretargeted Radioimmunotherapy Based on the Inverse Electron Demand Diels-Alder Reaction

Pretargeted Radioimmunotherapy Based on the Inverse Electron Demand Diels-Alder Reaction

Published on: January 29, 2019

An In Vitro Approach to Study Mitochondrial Dysfunction: A Cybrid Model

An In Vitro Approach to Study Mitochondrial Dysfunction: A Cybrid Model

Published on: March 9, 2022

相关概念视频

Electron Transport Chain: Complex I and II

Electron Transport Chain: Complex I and II

The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...

Cancer Therapies

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...

Treatment Resistant Cancers

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...